Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic Proteins Iftekhar MahmoodMartin D. Green Leading Article 30 September 2012 Pages: 331 - 347
Role of Cytochrome P450 Activity in the Fate of Anticancer Agents and in Drug Resistance Bertrand Rochat Review Article 30 September 2012 Pages: 349 - 366
Pharmacokinetic/Pharmacodynamic Relationships of Asparaginase Formulations Vassilios I. AvramisEduard H. Panosyan Review Article 30 September 2012 Pages: 367 - 393
Pharmacokinetics of Famotidine in Infants Larissa A. WenningM. Gail MurphyGregory L. Kearns Original Research Article 30 September 2012 Pages: 395 - 406
Topiramate Pharmacokinetics in Children and Adults with Epilepsy Dina BattinoDanilo CrociEmilio Perucca Original Research Article 30 September 2012 Pages: 407 - 416
Pharmacokinetic/Pharmacodynamic and Time-to-Event Models of Ribavirin-Induced Anaemia in Chronic Hepatitis C Michel TodMuriel Farcy-AfifPatrick Marcellin Original Research Article 30 September 2012 Pages: 417 - 428
Absence of Pharmacokinetic Interactions of the Combined Contraceptive Vaginal Ring NuvaRing® with Oral Amoxicillin or Doxycycline in Two Randomised Trials Peter DogteromMichiel W. van den HeuvelTorben Thomsen Original Research Article 30 September 2012 Pages: 429 - 438
Practical Guidelines to Interpret Plasma Concentrations of Antiretroviral Drugs Jonathan LeithRalf HinzmannDouglas Mayers Correspondence 30 September 2012 Pages: 439 - 439
The Authors’ Reply Bregt S. KappelhoffAlwin D. R. HuitemaJos H. Beijnen Correspondence 30 September 2012 Pages: 439 - 440